Effects of Oral Ibandronate Administered Daily or Intermittently on Fracture Risk in Postmenopausal Osteoporosis
Charles H. Chesnut(University of Washington), Arne Høiseth, Arne Skag(University of Bergen), J. A. Stakkestad, Jennifer Gilbride(Roche (United Kingdom)), Claus Christiansen(VA Eastern Colorado Health Care System), Dieter Felsenberg(Charité - Universitätsmedizin Berlin), Ralph C. Schimmer(Roche (Switzerland)), Pierre D. Delmas(Inserm), Hermann Huss, Robert R. Recker(Creighton University)
Cited by 1,225
Related Papers
The diagnosis of osteoporosis
|Journal of Bone and Mineral Research|1994|3.9k
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
|New England Journal of Medicine|2009|3.4k
Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes
|Nature Genetics|2006|2.3k
Effects of Raloxifene on Bone Mineral Density, Serum Cholesterol Concentrations, and Uterine Endometrium in Postmenopausal Women
|New England Journal of Medicine|1997|1.6k
A Mutation in the LDL Receptor–Related Protein 5 Gene Results in the Autosomal Dominant High–Bone-Mass Trait
|The American Journal of Human Genetics|2002|1.3k